305 related articles for article (PubMed ID: 12950120)
1. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
Lee KB; Kim UK
Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
[TBL] [Abstract][Full Text] [Related]
2. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
4. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency.
Coll E; Campos B; González-Núñez D; Botey A; Poch E
J Nephrol; 2003; 16(3):357-64. PubMed ID: 12832734
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
[TBL] [Abstract][Full Text] [Related]
6. Angiotensinogen gene polymorphisms and progression of chronic kidney disease in ADPKD patients.
Gnanasambandan R; Elumalai R; Soundararajan P; Lakkakula BVKS
Clin Exp Nephrol; 2016 Aug; 20(4):561-568. PubMed ID: 26482465
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease.
Raizada V; Skipper B; Luo W; Garza L; Hines CW; Harford AA; Zager PG; Griffith J; Raj D; Spalding CT
Kidney Int; 2005 Sep; 68(3):1186-9. PubMed ID: 16105049
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
[TBL] [Abstract][Full Text] [Related]
9. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Lee KB; Kim UK; Lee CC
J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
[TBL] [Abstract][Full Text] [Related]
11. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
12. [Progression of autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms].
Azurmendi P; Fraga A; Muchnik C; Dos Ramos Farias M; Galan F; Guerra D; O'Flaherty M; Arrizurieta E; Martin R
Medicina (B Aires); 2004; 64(2):139-42. PubMed ID: 15628301
[TBL] [Abstract][Full Text] [Related]
13. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan.
Chang HR; Cheng CH; Shu KH; Chen CH; Lian JD; Wu MY
J Chin Med Assoc; 2003 Jan; 66(1):51-6. PubMed ID: 12728975
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.
Buraczyńska M; Grzebalska A; Spasiewicz D; Orłowska G; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):330-6. PubMed ID: 12898858
[TBL] [Abstract][Full Text] [Related]
15. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
[TBL] [Abstract][Full Text] [Related]
16. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O
Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315
[TBL] [Abstract][Full Text] [Related]
17. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
[TBL] [Abstract][Full Text] [Related]
18. [Renin-angiotensin system genes in chronic glomerulonephritis].
Buraczyńska M; Jóźwiak L; Spasiewicz D; Nowicka T; Ksiazek A
Pol Arch Med Wewn; 2001 Jun; 105(6):455-60. PubMed ID: 11865575
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men.
Frimat L; Philippe C; Maghakian MN; Jonveaux P; DE Ligny BH; Guillemin F; Kessler M
J Am Soc Nephrol; 2000 Nov; 11(11):2062-2067. PubMed ID: 11053482
[TBL] [Abstract][Full Text] [Related]
20. Association between gene polymorphisms of the components of the renin-angiotensin-aldosteron system, graft function, and the prevalence of hypertension, anemia, and erythrocytosis after kidney transplantation.
Kujawa-Szewieczek A; Kolonko A; Kocierz M; Szotowska M; Trusolt W; Karkoszka H; Gumprecht J; Chudek J; Więcek A
Transplant Proc; 2011 Oct; 43(8):2957-63. PubMed ID: 21996200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
